Table 1.
Demographic and Clinical Characteristics of Patients (N = 53)
| Mean age at time of assessment, years (SD) | 57.8 (8.2) |
|---|---|
| n (%) | |
| Male | 33 (62.3) |
| Married | 39 (73.6) |
| Race | |
| White non-Hispanic | 42 (79.3) |
| Other | 11 (20.7) |
| Employment status | |
| Working (full or part time) | 17 (32.1) |
| Retired | 12 (22.6) |
| Other | 24 (45.3) |
| Years of education | |
| ≤12 | 9 (16.9) |
| 13–16 | 31 (58.5) |
| ≥17 | 13 (24.5) |
| Charlson comorbidity score | |
| 0 | 37 (69.8) |
| 1 | 10(18.9) |
| 2 | 4(7.6) |
| 3 | 2(3.8) |
| Most-prevalent comorbid conditions | |
| Diabetes | 7 (13.2) |
| Renal disease | 4 (7.6) |
| Connective-tissue disease | 4 (7.6) |
| Myocardial infarction | 4 (7.6) |
| Disease stage | |
| 1 | 30 (56.6) |
| 2 | 13 (24.5) |
| 3 | 10 (18.9) |
| Number of induction cycles | |
| 1–2 | 11 (22.9) |
| 3–4 | 28 (58.3) |
| ≥5 | 9 (18.7) |
| Induction regimen | |
| Bortezomib-based | 46 (86.8) |
| Other | 7 (13.2) |